RNA polymerase rifampicin resistance mutations in Escherichia coli: sequence changes and dominance

Five recombinant plasmids, pBK2646, pBK611, pRC3, pRC4 and pRC5, carrying rpoB rifampicin-resistant RNA-polymerase genes were obtained. The sequence analysis of these plasmids revealed certain structural changes in the rpoB gene which specify corresponding alterations in the beta-subunit of RNA polymerase. Some functional properties of the corresponding mutant strains and their RNA polymerases have been investigated.     

RNA polymerase mutants of Escherichia coli. Streptolydigin resistance and its relation to rifampicin resistance

Summary Several streptolydigin-resistant mutants of Escherichia coli were shown to produce RNA polymerase with increased drug resistance due to a recessive mutation (stl) located between argH and thiA. With one mutant studied, enzyme reconstitution experiments directly demonstrated that the altered subunit is responsible for its drug resistance. It was also found that some mutations (rif or stv) conferring resistance to rifampicin (or streptovaricin) lead to a simultaneous change in resistance to streptolydigin, suggesting certain functional relationship between the polymerase structure affected by rif (or stv) and stl mutations. This inference was further supported by the results of cistron analysis and of extensive transductional mapping involving two stl and a number of rif mutations. Thus it was found that all the mutational sites affecting sensitivity of RNA polymerase to streptolydigin and to rifampicin are closely localized, with partial overlap to each other, within a short segment of the cistron which determines the structure of subunit. These results led us to propose that the subunit is directly responsible for catalyzing both initiation and chain elongation steps of RNA synthesis. The possible bearing of the present findings on the structure-function relationship of the polymerase is discussed.     

Mutation to rifampicin resistance at the beginning of the RNA polymerase beta subunit gene in Escherichia coli

Summary The unusual recombinant plasmid pRC19 carrying the N-terminal fragment of the Escherichia coli RNA polymerase rpoB gene was found to specify high level rifampicin resistance of E. coli cells. Sequence analysis of this plasmid revealed one substitution only: transversion GT, leading to amino acid substitution Val¹⁴⁶Phe. This mutational change marks the second domain of the subunit involved in rifampicin binding.     

A resonance Raman study on the interaction of rifampicin with Escherichia coli RNA polymerase

The technique of resonance Raman spectroscopy has been used to investigate the interaction of the antibiotic rifampicin with Escherichia coli RNA polymerase. Spectra were analyzed by generating the first derivative of each recorded spectrum using the Savitsky-Golay algorithm. The only band that shifted significantly in the resonance Raman spectrum of rifampicin upon the formation of the drug-core polymerase complex was the amide III band. It underwent an 8 cm-1 shift from 1306 cm-1 in aqueous solution to 1314 cm-1. A comparable shift was observed for the rifampicin-holoenzyme complex. Thus, the interaction of the sigma subunit with the core polymerase does not significantly alter the manner in which rifampicin interacts with RNA polymerase. The nature of this shift has been analyzed further by recording the resonance Raman spectrum of rifampicin in a variety of solvents with different hydrogen-bonding solvents (benzene and carbon disulfide) the amide III band was observed at approximately 1220 cm-1; in dimethyl sulfoxide, a weak hydrogen-bond acceptor, 1274 cm-1; in water, a strong hydrogen-bonding solvent, 1306 cm-1; and finally, in triethylamine, a stronger hydrogen-bonding solvent than water, it was observed at 1314 cm-1. Thus, as the hydrogen-bonding ability of the solvent increased, the amide III band shifted to higher frequency. Based on these results, the rifampicin binding site in RNA polymerase provides a stronger hydrogen-bonding environment for the amidic proton of rifampicin than is encountered when rifampicin is free in aqueous solution.     

Nucleotide substitutions in the rpoB gene leading to rifampicin resistance of E. coli RNA polymerase

Three new rif-r-mutations, obtained independently, were localized in the rpoB gene coding for the beta-subunit of DNA-dependent RNA polymerase of E. coli. Two of them led to identical Asp(516)-Asn amino acid substitution with relatively low resistance of corresponding E. coli strains to rifampicin. The third mutation affected the His 526 residue transforming it into Tyr and endowed the E. coli cells with a high resistance against rifampicin.